Hedge Fund - Redmile Group
Krystal Biotech Inc. (KRYS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $215,019,427 | 7.69% | 1,733,189 | $110.89 |
| 2 | 2023 - Q3 (2023-09-30) | $232,390,572 | 11.05% | 2,003,367 | $122.00 |
| 3 | 2023 - Q2 (2023-06-30) | $301,326,001 | 11.56% | 2,566,661 | $102.10 |
| 4 | 2023 - Q1 (2023-03-31) | $153,177,197 | 6.64% | 1,913,280 | $78.56 |
| 5 | 2022 - Q4 (2022-12-31) | $150,252,217 | 6.14% | 1,896,645 | $74.22 |
| 6 | 2022 - Q3 (2022-09-30) | $132,398,000 | 5.13% | 1,899,545 | $72.25 |
| 7 | 2022 - Q2 (2022-06-30) | $124,658,000 | 4.75% | 1,898,545 | $62.21 |
| 8 | 2022 - Q1 (2022-03-31) | $120,817,000 | 3.77% | 1,815,698 | $62.42 |
| 9 | 2021 - Q4 (2021-12-31) | $127,372,000 | 2.89% | 1,820,898 | $58.21 |
| 10 | 2021 - Q3 (2021-09-30) | $103,503,000 | 1.8% | 1,982,432 | $59.20 |
| 11 | 2021 - Q2 (2021-06-30) | $140,905,000 | 2.08% | 2,072,132 | $69.80 |
| 12 | 2021 - Q1 (2021-03-31) | $158,713,000 | 2.23% | 2,060,132 | $72.70 |
| 13 | 2020 - Q4 (2020-12-31) | $100,502,000 | 1.21% | 1,675,036 | $49.94 |
| 14 | 2020 - Q3 (2020-09-30) | $64,659,000 | 1.18% | 1,501,945 | $43.43 |
| 15 | 2020 - Q2 (2020-06-30) | $58,392,000 | 1.07% | 1,409,745 | $48.11 |
| 16 | 2020 - Q1 (2020-03-31) | $45,480,000 | 1.27% | 1,051,800 | $52.30 |
| 17 | 2019 - Q4 (2019-12-31) | $60,375,000 | 1.44% | 1,090,200 | $49.06 |
| 18 | 2019 - Q3 (2019-09-30) | $37,444,000 | 1.25% | 1,078,300 | $44.70 |
| 19 | 2019 - Q2 (2019-06-30) | $43,504,000 | 1.23% | 1,080,300 | $32.69 |
| 20 | 2019 - Q1 (2019-03-31) | $10,676,000 | 0.31% | 324,500 | $23.57 |
| 21 | 2018 - Q4 (2018-12-31) | $6,754,000 | 0.27% | 325,000 | $20.94 |
The displayed share prices are average quarterly stock market prices.